Variant report
Variant | nsv823743 |
---|---|
Chromosome Location | chr6:76223606-76231151 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:76222296..76224632-chr6:76225087..76227864,2 | K562 | blood: | |
2 | chr6:76228629..76230410-chr6:76233743..76235799,2 | K562 | blood: | |
3 | chr6:76230814..76232317-chr6:76310930..76313052,2 | MCF-7 | breast: | |
4 | chr6:76222296..76224632-chr6:76225087..76227864,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000112701 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs551923148 | chr6:76225040-76225041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs187805864 | chr6:76225075-76225076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs549948586 | chr6:76225101-76225102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs568441272 | chr6:76225114-76225115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs142516287 | chr6:76225156-76225157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs192624156 | chr6:76225164-76225165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs150580204 | chr6:76225239-76225240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs539613366 | chr6:76225246-76225247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs139640741 | chr6:76225270-76225271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs1932522 | chr6:76225303-76225304 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs537138259 | chr6:76225365-76225366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs144387999 | chr6:76225366-76225367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs573534354 | chr6:76225367-76225368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs541342605 | chr6:76225377-76225378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs568615843 | chr6:76225378-76225379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs553275714 | chr6:76225423-76225424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs147833738 | chr6:76225430-76225431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs533850584 | chr6:76225445-76225446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs75098842 | chr6:76225474-76225475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs182258850 | chr6:76225570-76225571 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs75368375 | chr6:76225586-76225587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs139970760 | chr6:76225673-76225674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs561951137 | chr6:76225681-76225682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs145397817 | chr6:76225690-76225691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs145251090 | chr6:76225775-76225776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs111980104 | chr6:76225848-76225849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533428738 | chr6:76225849-76225850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs551726239 | chr6:76225915-76225916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs10943255 | chr6:76225928-76225929 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs34354658 | chr6:76225934-76225935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs62414219 | chr6:76226073-76226074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs567936125 | chr6:76226091-76226092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs536750023 | chr6:76226107-76226108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs1591509 | chr6:76226108-76226109 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs567286051 | chr6:76226120-76226121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs534630865 | chr6:76226131-76226132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs552989321 | chr6:76226150-76226151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs74773998 | chr6:76226155-76226156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs149128758 | chr6:76226173-76226174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs538933131 | chr6:76226188-76226189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs539684523 | chr6:76230831-76230832 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs566889547 | chr6:76230868-76230869 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs77380678 | chr6:76230907-76230908 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs527659997 | chr6:76231010-76231011 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs552522475 | chr6:76231032-76231033 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs572893475 | chr6:76231109-76231110 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs571093471 | chr6:76231144-76231145 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Developmental delay | 21147756 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Lung cancer | 16773561 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:76225000-76226200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |